| Financial Year |
March 31 2023 |
| Monetary Funds |
302,160,597.58 |
| Held-for-trading Financial Assets |
25,020,087.67 |
| Notes Receivable |
-- |
| Accounts Receivable |
310,717,312.87 |
| Advances to Suppliers |
10,938,841.44 |
| Other Receivables |
6,838,401.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
75,711,580.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,491,439.03 |
| Total Current Assets |
902,340,034.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
189,366,394.78 |
| Under-construction Projects |
17,707,309.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
533,092.95 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
14,842,694.02 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
230,027,482.46 |
| Total Assets |
1,132,367,516.64 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
64,358,010.54 |
| Accounts Payable |
167,305,094.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,903,787.25 |
| Taxes Payable |
9,192,903.07 |
| Interest Payable |
-- |
| Dividend Payable |
86,800.00 |
| Other payables |
11,285,578.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
454,338.21 |
| Other Current Liabilities |
2,293,400.63 |
| Sub-Total of Current Liabilities |
284,485,268.91 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
29,720.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
77,740,490.95 |
| Total Liabilities |
362,225,759.86 |
| Paid-In Capital(Or Share Stock) |
149,790,000.00 |
| Capital Surplus |
323,128,912.57 |
| Surplus Reserve |
32,330,279.32 |
| LESS:Treasury Stock |
9,107,800.00 |
| Undistributed Profits |
275,467,190.24 |
| Minority Stockholder's Interest |
-1,466,825.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
771,608,582.13 |
| Owner's Equity（Stockholder's Equity） |
770,141,756.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,132,367,516.64 |
